International Stem Cell (ISCO) Construction in Progress (2014)
International Stem Cell's (ISCO) quarterly Construction in Progress came in at $64000.0 in Q3 2014, up 156.0% quarter-over-quarter from $25000.0 in Q2 2014.
Powered by 
Analysis
International Stem Cell (ISCO) Construction in Progress (2014) Analysis & Trends
International Stem Cell (ISCO) has reported Construction in Progress for 1 consecutive years, with $64000.0 the latest figure, recorded in Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 328,000.00 |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.40 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | - |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn | - |